US Stock MarketDetailed Quotes
MDWD MediWound
- 16.480
- -0.280-1.67%
Close Nov 22 16:00 ET
- 15.980
- -0.500-3.03%
Post 17:39 ET
177.82MMarket Cap-7629P/E (TTM)
16.810High16.400Low29.27KVolume16.810Open16.760Pre Close485.65KTurnover0.51%Turnover RatioLossP/E (Static)10.79MShares24.00052wk High9.95P/B95.22MFloat Cap8.41052wk Low--Dividend TTM5.78MShs Float135.170Historical High--Div YieldTTM2.45%Amplitude7.100Historical Low16.593Avg Price1Lot Size
MediWound Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 31.00%-3.62M | -806.75%-4.61M | 11.95%-10.47M | -230.75%-2.62M | 28.80%-3.25M | 0.06%-5.25M | 116.04%652K | -33.30%-11.89M | 189.49%2M | -62.03%-4.57M |
| Net income from continuing operations | -788.32%-6.31M | -163.44%-9.73M | 65.73%-6.72M | 76.63%-1.74M | 47.70%-2.2M | 121.04%916K | -2.90%-3.69M | -44.63%-19.6M | -79.25%-7.46M | -25.53%-4.2M |
| Operating gains losses | 139.98%1.95M | 1,312.16%6.18M | -169.76%-8.04M | -117.71%-1.95M | -1,198.15%-701K | -1,634.59%-4.88M | -292.45%-510K | 9,391.94%11.52M | 9,803.60%10.99M | -1,250.00%-54K |
| Depreciation and amortization | 13.33%357K | 21.45%368K | 2.44%1.3M | 21.83%346K | 0.30%339K | -4.26%315K | -5.61%303K | 2.75%1.27M | 2.90%284K | 0.90%338K |
| Other non cash items | 80.77%-80K | -218.85%-145K | -691.74%-1.29M | 55.23%-531K | -157.20%-465K | -277.78%-416K | -65.83%122K | -87.07%218K | -430.36%-1.19M | 60.36%813K |
| Change In working capital | 83.98%-304K | -147.13%-1.8M | 132.25%2.34M | 175.39%962K | 75.17%-539K | 6.64%-1.9M | 316.04%3.81M | -4,571.60%-7.24M | -261.72%-1.28M | -205.77%-2.17M |
| -Change in receivables | 253.31%417K | -103.66%-238K | 166.00%4.76M | 75.10%-1.22M | 59.05%-249K | 78.06%-272K | 1,533.70%6.51M | -4,448.19%-7.22M | -998.72%-4.92M | 3.34%-608K |
| -Change in inventory | 117.79%103K | 23.16%-448K | -25.66%-906K | 792.04%782K | -478.42%-526K | -1,464.86%-579K | 17.89%-583K | -380.54%-721K | -263.77%-113K | -18.71%139K |
| -Change in payables and accrued expense | 21.30%-824K | 47.52%-1.11M | -318.99%-1.52M | -62.59%1.4M | 113.87%236K | -38.49%-1.05M | -252.50%-2.12M | 366.28%695K | 2,069.36%3.75M | -575.40%-1.7M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 31.00%-3.62M | -806.75%-4.61M | 11.95%-10.47M | -230.75%-2.62M | 28.80%-3.25M | 0.06%-5.25M | 116.04%652K | -33.30%-11.89M | 189.49%2M | -62.03%-4.57M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 110.91%2.85M | 76.03%-1.78M | -7,035.34%-34.32M | 109.85%5.03M | -7,185.00%-5.83M | -888.93%-26.08M | -4,551.88%-7.44M | -113.56%-481K | 2,165.52%2.4M | 37.98%-80K |
| Net PPE purchase and sale | -183.19%-3.02M | 16.35%-1.26M | -1,064.68%-6.46M | -1,169.54%-2.21M | -1,930.12%-1.69M | -671.74%-1.07M | -840.63%-1.51M | -13.50%-555K | -50.00%-174K | 35.66%-83K |
| Net investment purchase and sale | 120.86%5.34M | 81.89%-1.13M | ---29.8M | 160.70%6.52M | ---4.49M | -924.01%-25.59M | ---6.24M | --0 | --2.5M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 110.91%2.85M | 76.03%-1.78M | -7,035.34%-34.32M | 109.85%5.03M | -7,185.00%-5.83M | -888.93%-26.08M | -4,551.88%-7.44M | -113.56%-481K | 2,165.52%2.4M | 37.98%-80K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 74.57%-103K | -102.88%-699K | -35.92%22.92M | -101.39%-204K | -106.17%-727K | 44.37%-405K | 140.68%24.25M | 3,506.10%35.76M | 8,370.06%14.64M | 3,408.15%11.78M |
| Net issuance payments of debt | -36.31%-214K | -37.85%-244K | ---- | ---- | -32.60%-240K | ---157K | 0.56%-177K | ---- | ---- | -2.84%-181K |
| Net common stock issuance | --0 | -98.02%499K | -35.10%24.91M | --0 | --0 | 55.40%-248K | 141.50%25.16M | --38.38M | --16.47M | --12.05M |
| Proceeds from stock option exercised by employees | --111K | ---- | --0 | ---- | ---- | ---- | ---- | 233.33%10K | ---- | ---- |
| Net other financing activities | ---- | -31.22%-954K | 24.14%-1.99M | 67.15%-778K | -407.29%-487K | ---- | -348.77%-727K | -149.38%-2.63M | -241.70%-2.37M | 46.67%-96K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 74.57%-103K | -102.88%-699K | -35.92%22.92M | -101.39%-204K | -106.17%-727K | 44.37%-405K | 140.68%24.25M | 3,506.10%35.76M | 8,370.06%14.64M | 3,408.15%11.78M |
| Net cash flow | ||||||||||
| Beginning cash position | -90.82%4.69M | -64.99%11.87M | 206.85%33.9M | -37.75%9.28M | 147.98%19.17M | 206.41%51.02M | 206.85%33.9M | -36.43%11.05M | 8.93%14.91M | -54.52%7.73M |
| Current changes in cash | 97.22%-881K | -140.61%-7.09M | -193.47%-21.87M | -88.39%2.21M | -237.51%-9.81M | -268.19%-31.73M | 198.39%17.46M | 464.57%23.4M | 852.93%19.03M | 315.89%7.13M |
| Effect of exchange rate changes | 87.50%-15K | 73.59%-89K | 70.86%-160K | 959.09%378K | -280.00%-81K | 60.40%-120K | -36.44%-337K | -723.86%-549K | 59.63%-44K | 742.86%45K |
| End cash Position | -80.23%3.79M | -90.82%4.69M | -64.99%11.87M | -64.99%11.87M | -37.75%9.28M | 147.98%19.17M | 206.41%51.02M | 206.85%33.9M | 206.85%33.9M | 8.93%14.91M |
| Free cash flow | -5.11%-6.64M | -587.81%-5.87M | -36.09%-16.93M | -364.18%-4.82M | -6.17%-4.94M | -17.14%-6.32M | 79.81%-853K | -32.27%-12.44M | 177.67%1.83M | -57.75%-4.65M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data